Infectious
diseases are medical conditions or disorders caused by microorganisms such as
bacteria, fungi, viruses and other parasites. Several organisms are present in
and on human bodies. Some organisms are normally harmless and even helpful.
However, under certain circumstances, some organisms cause diseases. Infectious
diseases spread from one person to another. Moreover, some are transmitted by
bites from insects and animals. Infectious diseases also occur by consumption
of contaminated food and water.
Signs and
symptoms of infectious diseases depend on the type of organism and infection.
Some of the most common symptoms of infectious diseases include fatigue and
fever. Mild complaints of infectious diseases treated from rest and home
remedies, while some life-threatening infections require hospitalization.
Infectious diseases, such chickenpox and measles are prevented by vaccination.
Frequent and thorough hand-washing also protect human body from infectious
diseases.
Download Report
Sample at:
North
America dominates the global infectious disease treatment market followed by
Europe. The U.S., followed by Canada, is the largest market for infectious
disease treatment in the North American region. Key driving factor for
infectious disease treatment market in the region is increasing research
activities on various types of diseases. Germany, France and the U.K. are some
of the largest markets for infectious diseases in Europe. However, Asia-Pacific
represents the fastest growing region in the global infectious disease
treatment market. This is due to minimal wages and availability of skilled
professionals in the region. These factors attract drug manufacturing companies
to invest in the Asian countries. In addition, in developing countries, such as
China and India, government has launched several programs and initiatives to
increase awareness about infectious diseases. China, Japan and India are
largest infectious disease treatment markets in the region.
Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=infectious-disease-treatment
Increasing prevalence of the infectious diseases is key driving factor for the global infectious disease treatment market. Increasing awareness and extensive R&D drugs pipelines are also enhancing the growth of global infectious disease market. Moreover, introduction of novel drugs, such as direct-acting antivirals, boosts the growth of global infectious disease treatment market.
However,
patent expiry of various major drugs and presence of generic drugs are key
restraint of the global infectious disease treatment market. Stringent
regulations and legislations and side-effects of anti-infective drugs also
hinder the growth of global infectious disease treatment market. Rapid product
launches and increasing mergers and acquisitions between drug manufactures are emerging
trends of the global infectious disease treatment market.
Some of the
major competitors in the global
infectious disease treatment market are F. Hoffmann-La Roche,
GlaxoSmithKline, Merck, Johnson & Johnson, Pfizer, Gilead Sciences, Bristol-Myers Squibb Company, AstraZeneca,
Bayer AG, Novartis, Sanofi, AbbVie and Auritec Pharmaceuticals.
